US2528281080
US2528281080
Dianthus Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 4.5B EUR | 5.34B EUR | 4.58B EUR |
Enterprise Value | 3.73B EUR | 5.23B EUR | 3.95B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -17.86x | -- | -- |
Price to Sales | 2,364.95x | 2,805.54x | 3,428.58x |
Price to Book | 3.85x | 4.56x | 3.81x |
EV/Revenue | 1,956.48x | 2,748.15x | 2,959.79x |
EV/EBITDA | -17.11x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -2.05% | -2.91% | -2.85% |